SE9301324D0 - New method of treatment - Google Patents

New method of treatment

Info

Publication number: SE9301324D0
Authority: SE; Sweden
Prior art keywords: treatment; new method; bacteraemia; adenosine; activation
Prior art date: 1993-04-21

Application number

SE19939301324A

Other languages

English (en)

Swedish (sv)

Inventor

*Sollevi Alf

Original Assignee

Item Development Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-21

Filing date

1993-04-21

Publication date

1993-04-21

1993-04-21 Application filed by Item Development Ab filed Critical Item Development Ab

1993-04-21 Priority to SE19939301324A priority Critical patent/SE9301324D0/xx

1993-04-21 Publication of SE9301324D0 publication Critical patent/SE9301324D0/xx

1993-10-28 Priority to US08/144,803 priority patent/US5648341A/en

1994-01-03 Priority to AT94903224T priority patent/ATE185484T1/de

1994-01-03 Priority to JP6506175A priority patent/JPH08508710A/ja

1994-01-03 Priority to DE69421174T priority patent/DE69421174T2/de

1994-01-03 Priority to EP94903224A priority patent/EP0695185B1/de

1994-01-03 Priority to AU57246/94A priority patent/AU5724694A/en

1994-01-03 Priority to PCT/SE1994/000001 priority patent/WO1994004017A2/en

1994-01-03 Priority to CA002160689A priority patent/CA2160689C/en

Links

238000000034 method Methods 0.000 title abstract 3
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 2
208000031729 Bacteremia Diseases 0.000 abstract 1
239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
230000004913 activation Effects 0.000 abstract 1
229960005305 adenosine Drugs 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
238000001990 intravenous administration Methods 0.000 abstract 1
210000000265 leukocyte Anatomy 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1
210000003462 vein Anatomy 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

SE19939301324A 1993-04-21 1993-04-21 New method of treatment SE9301324D0 (sv)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
SE19939301324A SE9301324D0 (sv)	1993-04-21	1993-04-21	New method of treatment
US08/144,803 US5648341A (en)	1993-04-21	1993-10-28	Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution
AT94903224T ATE185484T1 (de)	1993-04-21	1994-01-03	Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge
JP6506175A JPH08508710A (ja)	1993-04-21	1994-01-03	新規処置方法
DE69421174T DE69421174T2 (de)	1993-04-21	1994-01-03	Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge
EP94903224A EP0695185B1 (de)	1993-04-21	1994-01-03	Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge
AU57246/94A AU5724694A (en)	1993-04-21	1994-01-03	New method of treatment
PCT/SE1994/000001 WO1994004017A2 (en)	1993-04-21	1994-01-03	New method of treatment
CA002160689A CA2160689C (en)	1993-04-21	1994-01-03	New method of treatment

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE19939301324A SE9301324D0 (sv)	1993-04-21	1993-04-21	New method of treatment

Publications (1)

Publication Number	Publication Date
SE9301324D0 true SE9301324D0 (sv)	1993-04-21

Family

ID=20389651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE19939301324A SE9301324D0 (sv)	1993-04-21	1993-04-21	New method of treatment

Country Status (9)

Country	Link
US (1)	US5648341A (de)
EP (1)	EP0695185B1 (de)
JP (1)	JPH08508710A (de)
AT (1)	ATE185484T1 (de)
AU (1)	AU5724694A (de)
CA (1)	CA2160689C (de)
DE (1)	DE69421174T2 (de)
SE (1)	SE9301324D0 (de)
WO (1)	WO1994004017A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL121272A (en) *	1997-07-10	2000-06-01	Can Fite Technologies Ltd	Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
US5998386A (en) *	1997-09-19	1999-12-07	Feldman; Arthur M.	Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
CN101453984A (zh) *	2006-03-31	2009-06-10	艾登欧比公司	使用腺苷和肌苷组合用于诊断和治疗的组合物、方法和试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5104859A (en) *	1985-09-24	1992-04-14	Solimedco Aktiebolag	Continuous administration of adenosine to reduce pulmonary vascular resistance
US5231086A (en) *	1985-09-24	1993-07-27	Item Development Aktiebolag	Continuous administration adenosine to increase myocardial blood flow

1993
- 1993-04-21 SE SE19939301324A patent/SE9301324D0/xx unknown
- 1993-10-28 US US08/144,803 patent/US5648341A/en not_active Expired - Lifetime
1994
- 1994-01-03 WO PCT/SE1994/000001 patent/WO1994004017A2/en not_active Ceased
- 1994-01-03 AU AU57246/94A patent/AU5724694A/en not_active Abandoned
- 1994-01-03 EP EP94903224A patent/EP0695185B1/de not_active Expired - Lifetime
- 1994-01-03 DE DE69421174T patent/DE69421174T2/de not_active Expired - Fee Related
- 1994-01-03 CA CA002160689A patent/CA2160689C/en not_active Expired - Lifetime
- 1994-01-03 AT AT94903224T patent/ATE185484T1/de not_active IP Right Cessation
- 1994-01-03 JP JP6506175A patent/JPH08508710A/ja active Pending

Also Published As

Publication number	Publication date
EP0695185B1 (de)	1999-10-13
CA2160689A1 (en)	1994-03-03
AU5724694A (en)	1994-03-15
EP0695185A1 (de)	1996-02-07
CA2160689C (en)	1999-11-02
WO1994004017A2 (en)	1994-03-03
ATE185484T1 (de)	1999-10-15
JPH08508710A (ja)	1996-09-17
DE69421174D1 (de)	1999-11-18
WO1994004017A3 (en)	1994-09-01
DE69421174T2 (de)	2000-02-10
US5648341A (en)	1997-07-15

Similar Documents

Publication	Publication Date	Title
AU5947396A (en)	1996-10-31	Dimer of molecular variant of apolipoprotein and processes for the production thereof
RU93054168A (ru)	1996-10-10	Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе
DE69526853D1 (de)	2002-07-04	Hemmung der fortpflanzung von arterienglattmuskelzellen
CA2157925A1 (en)	1994-09-15	Treatment of Mycobacterial Diseases by Administration of Bactericidal/Permeability-Increasing Protein Products
EP0372670A3 (de)	1991-08-21	Hirudinverwandte Peptide zur Verhinderung der Plättchenaggregation
RU92016490A (ru)	1995-06-19	Новые 2-сахаринилметил(арил и арокси)ацетаты, применимые в качестве ингибиторов протеолитических ферментов, их композиции и способ их применения
GR3036691T3 (en)	2001-12-31	Dna sequences related to isolated fragile x syndrome
GR3004988T3 (de)	1993-04-28
CA2087271A1 (en)	1992-02-16	Superior thrombomodulin analogs for pharmaceutical use
SE9301324D0 (sv)	1993-04-21	New method of treatment
WO1990013281A3 (en)	2004-04-22	Method of suppressing hiv infection
FR2707638B1 (fr)	1995-08-18	Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
DE69007065D1 (de)	1994-04-07	Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
JPS6456699A (en)	1989-03-03	Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug
ES8704962A1 (es)	1987-04-16	Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
FR2409996A1 (fr)	1979-06-22	15-epi-prostacycline et analogues, utiles notamment comme agents antithrombotiques et thrombolytiques et leur procede de preparation
DK0632028T3 (da)	2003-07-21	Optisk aktivt 2-nitroimidazolderivat, fremgangsmåde til fremstilling af samme og mellemprodukt til fremstilling af samme
DK360388A (da)	1989-01-02	Laegemiddel til behandling af hjerteinsufficiens
CA2157856A1 (en)	1996-03-10	Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
EP0317933A3 (de)	1990-09-12	Behandlung von Fibromyalgie
DK0722460T3 (da)	2000-03-20	Peptidderivater der er terapeutisk aktive i blodkoaguleringskaskaden, fremgangsmåde til fremstilling heraf og farmaceutiske
IT8720288A0 (it)	1987-04-27	Forno per il trattamento di articoli di pelletteria o simili,quali le calzature, applicabile a catene continue di lavorazione.
DK0688786T3 (da)	1997-09-15	Hydrazino- og hydroxyamino-14beta-hydroxyandrostanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse.
FR2433021A1 (fr)	1980-03-07	Oligomeres de pyridocarbazoles et leur application therapeutique
ITTO960331A0 (it)	1996-04-24	Corredo di infusione, particolarmente per la somministrazione parente-rale di acido tioctico.